Alnylam Pharmaceuticals
ALNY
#618
Rank
C$45.10 B
Marketcap
$348.49
Share price
3.69%
Change (1 day)
76.95%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $416.35 CAD on 2024-10-16

Lowest end of day price: $5.47 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$18.36-0.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$834.84 0.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$83.73-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.95-3.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.82-1.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$155.35 0.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$72.48-2.28%๐Ÿ‡ซ๐Ÿ‡ท France
$20.60 1.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel